Dr. Daniel De Carvalho Receives 2025 Gairdner Award
MBP scientist Dr. Daniel De Carvalho has been named the recipient of the 2025 Peter Gilgan Canadian Gairdner Momentum Award. This prestigious award is bestowed upon Canadian mid-career investigators who have made exceptional scientific research contributions with continued potential for impact on human health.
Dr. De Carvalho is being recognized by Gairdner for "the ground-breaking discovery of the role of transposable elements in regulating anti-tumour immunity through viral mimicry, which holds transformative potential for cancer therapy, and for pioneering the development of a novel blood-based test for early cancer detection, classification, and therapy monitoring.”
Gairdner states that Daniel’s contributions “have not only advanced our understanding of cancer biology but also influenced clinical practice, offering hope for more effective and personalized treatments and cancer management. His research continues to shape the future of cancer therapy and diagnostics, making a profound impact on patient outcomes worldwide.”
Please join the department in congratulating Dr. De Carvalho on this outstanding achievement.